Khatkar Harman, See Abbas
Trauma and Orthopaedics, Royal Berkshire Hospital, Reading, GBR.
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, GBR.
Cureus. 2021 Mar 13;13(3):e13869. doi: 10.7759/cureus.13869.
Bone, as a physiological and anatomical construct, displays remarkable intrinsic healing capacity. The overwhelming majority of fractures will heal satisfactorily, if aligned anatomically, compressed and immobilised appropriately. Of the 10% of fractures that do not heal, even under ideal mechanical and biological conditions, further consideration must be given to augment bone healing. Management strategies for non-union pose a significant clinical challenge to the practicing orthopaedic surgeon. Stem cell therapy is beginning to demonstrate significant potential for augmented bone repair in the context of non-union. This review attempts to contextualise the function of stem cells within this clinical setting, reviewing the relevant cellular mechanisms and clinical applications. From evaluating the literature base, there is a lack of high-quality evidence examining the role of mesenchymal stem cells (MSCs) within this research focus. Appropriately designed randomised controlled trials are required to evaluate this research area further, with a view to guiding future treatment options for the practicing orthopaedic surgeon.
骨骼作为一种生理和解剖结构,具有显著的内在愈合能力。如果骨折部位能进行解剖复位、适当加压并固定,绝大多数骨折都能顺利愈合。即使在理想的力学和生物学条件下,仍有10%的骨折无法愈合,对此必须进一步考虑促进骨愈合的方法。骨折不愈合的治疗策略给骨科医生带来了重大的临床挑战。干细胞疗法在骨折不愈合的情况下,已开始展现出促进骨修复的巨大潜力。本综述试图在此临床背景下阐述干细胞的功能,回顾相关的细胞机制和临床应用。通过评估文献库发现,在这一研究重点领域,缺乏高质量证据来检验间充质干细胞(MSC)的作用。需要设计恰当的随机对照试验,以进一步评估该研究领域,为骨科医生指导未来的治疗选择提供依据。